Cambridge Bioscience Limited

POWER SEARCH PRICING

SOLUTIONS

cambridge bioscience limited Company Information

Live

MatureMidRapid

Company Number

04382252

Website

http://bioscience.co.uk

Registered Address

munro house trafalgar way, bar hill, cambridge, CB23 8SQ

Industry

Agents specialised in the sale of other particular products

Telephone

01223316855

Next Accounts Due

June 2024

Group Structure

View All

Directors

Michael Kerins17 Years

Shareholders

europa biosite holding ab 100%

cambridge bioscience limited Estimated Valuation

£23.6m

Pomanda estimates the enterprise value of CAMBRIDGE BIOSCIENCE LIMITED at £23.6m based on an EBITDA of £3.5m and a 6.81x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Cambridge Bioscience Limited is a live company located in cambridge, CB23 8SQ with a Companies House number of 04382252. It operates in the agents specialized in the sale of other particular products sector, SIC Code 46180. Founded in February 2002, it's largest shareholder is europa biosite holding ab with a 100% stake. Cambridge Bioscience Limited is a mature, mid sized company, Pomanda has estimated its turnover at £16.7m with rapid growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Cambridge Bioscience Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 10 measures and has 0 areas for improvement. Company Health Check FAQs

Health Rating5out of 5

10 Strong

2 Regular

0 Weak

Size

annual sales of £16.7m, make it larger than the average company (£7.7m)

Growth

3 year (CAGR) sales growth of 46%, show it is growing at a faster rate (2.8%)

EXPORT

Cambridge Bioscience Limited's latest turnover from September 2022 is £16.7 million and the company has net assets of £5.2 million. According to their latest financial statements, Cambridge Bioscience Limited has 29 employees and maintains cash reserves of £3.3 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Turnover	16,660,913	23,173,813	6,384,717	5,340,440	4,783,471	5,245,363	4,503,612	5,821,269	6,468,611	4,936,931	5,624,750	3,944,776	3,148,368	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	9,968,006	11,428,162	4,589,642	3,911,955	3,484,566	3,901,587	3,267,468	4,228,982	4,830,581	3,672,869	4,189,436	2,950,882	2,292,070	0
Gross Profit	6,692,907	11,745,651	1,795,075	1,428,485	1,298,905	1,343,776	1,236,144	1,592,287	1,638,030	1,264,062	1,435,314	993,895	856,297	0
Admin Expenses	3,294,213	4,324,307	872,842	1,022,816	1,271,920	1,137,792	1,245,722	1,395,649	1,615,384	897,210	1,305,191	961,163	1,167,950	-764,574
Operating Profit	3,398,694	7,421,344	922,233	405,669	26,985	205,984	-9,578	196,638	22,646	366,852	130,123	32,732	-311,653	764,574
Interest Payable	5,740	10,787	31,955	39,908	28,355	22,641	19,342	14,400	16,894	19,434	20,901	21,728	11,202	0
Interest Receivable	24,485	35,296	308	837	727	533	726	876	790	1,270	847	362	999	864
Pre-Tax Profit	3,417,439	7,445,853	890,586	366,598	-644	183,877	-28,194	183,114	6,542	348,687	110,068	11,366	-321,855	765,438
Tax	-653,042	-1,418,685	-169,211	-69,654	0	-34,937	0	-36,623	-1,374	-80,198	-26,416	-2,955	0	-214,322
Profit After Tax	2,764,397	6,027,168	721,375	296,944	-644	148,940	-28,194	146,491	5,168	268,489	83,652	8,411	-321,855	551,115
Dividends Paid	5,100,000	340,000	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-2,335,603	5,687,168	721,375	296,944	-644	148,940	-28,194	146,491	5,168	268,489	83,652	8,411	-321,855	551,115
Employee Costs	1,621,088	2,356,752	1,512,736	1,405,779	1,280,122	1,197,350	690,000	827,040	891,048	704,870	760,395	555,566	492,556	0
Number Of Employees	29	26	32	29	28	28	15	19	21	17	18	14	13	0
EBITDA*	3,472,548	7,459,701	957,791	451,032	70,197	248,713	46,862	253,246	64,814	402,664	168,883	71,491	-275,784	784,613

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Tangible Assets	677,612	638,887	654,914	676,481	701,845	672,374	708,289	764,010	798,620	751,250	761,587	781,032	811,396	447,917
Intangible Assets	0	0	0	0	0	0	0	2,000	4,000	6,000	8,000	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	42,756	40,924	50,000	0	0	0	0
Total Fixed Assets	677,612	638,887	654,914	676,481	701,845	672,374	708,289	808,766	843,544	807,250	769,587	781,032	811,396	447,917
Stock & work in progress	378,638	1,199,214	324,938	303,134	366,123	337,399	350,241	258,135	198,159	94,063	72,223	40,479	36,750	22,031
Trade Debtors	1,322,998	2,620,803	1,299,942	883,480	670,214	836,555	681,293	968,595	1,158,924	879,497	969,063	784,217	584,499	517,968
Group Debtors	1,071,624	0	0	84,626	76,361	0	0	0	0	0	0	0	0	0
Misc Debtors	145,871	804,251	512,079	468,171	438,361	180,813	192,364	0	0	0	0	4,101	0	0
Cash	3,297,680	4,577,596	447,329	169,556	53,556	140,227	286,481	294,212	56,084	259,983	247,815	90,783	54,130	345,552
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	6,216,811	9,201,864	2,584,288	1,908,967	1,604,615	1,494,994	1,510,379	1,520,942	1,413,167	1,233,543	1,289,101	919,580	675,379	885,551
total assets	6,894,423	9,840,751	3,239,202	2,585,448	2,306,460	2,167,368	2,218,668	2,329,708	2,256,711	2,040,793	2,058,688	1,700,612	1,486,775	1,333,468
Bank overdraft	0	376,065	55,062	314,755	83,801	41,335	107,818	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	1,018,213	784,007	620,754	591,239	777,090	816,237	997,575	1,171,732	1,256,577	1,026,299	1,280,516	988,608	760,921	713,373
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	610,972	971,755	320,336	164,423	113,595	168,956	75,420	0	0	0	0	0	0	0
total current liabilities	1,629,185	2,131,827	996,152	1,070,417	974,486	1,026,528	1,180,813	1,171,732	1,256,577	1,026,299	1,280,516	988,608	760,921	713,373
loans	0	121,331	342,781	335,121	448,786	266,238	309,105	202,025	241,049	278,781	319,203	323,903	344,666	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	192,463	138,801	130,136	126,256	146,667	146,667	64,943
provisions	32,781	19,533	19,377	20,393	20,615	11,385	14,473	21,017	24,304	14,765	10,390	2,763	4,261	2,537
total long term liabilities	32,781	140,864	362,158	355,514	469,401	277,623	323,578	415,505	404,154	423,682	455,849	473,333	495,594	67,480
total liabilities	1,661,966	2,272,691	1,358,310	1,425,931	1,443,887	1,304,151	1,504,391	1,587,237	1,660,731	1,449,981	1,736,365	1,461,941	1,256,515	780,853
net assets	5,232,457	7,568,060	1,880,892	1,159,517	862,573	863,217	714,277	742,471	595,980	590,812	322,323	238,671	230,260	552,615
total shareholders funds	5,232,457	7,568,060	1,880,892	1,159,517	862,573	863,217	714,277	742,471	595,980	590,812	322,323	238,671	230,260	552,615

	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Operating Activities
Operating Profit	3,398,694	7,421,344	922,233	405,669	26,985	205,984	-9,578	196,638	22,646	366,852	130,123	32,732	-311,653	764,574
Depreciation	73,854	38,357	35,558	45,363	43,212	42,729	54,440	54,608	40,168	33,812	36,760	38,759	35,869	20,039
Amortisation	0	0	0	0	0	0	2,000	2,000	2,000	2,000	2,000	0	0	0
Tax	-653,042	-1,418,685	-169,211	-69,654	0	-34,937	0	-36,623	-1,374	-80,198	-26,416	-2,955	0	-214,322
Stock	-820,576	874,276	21,804	-62,989	28,724	-12,842	92,106	59,976	104,096	21,840	31,744	3,729	14,719	22,031
Debtors	-884,561	1,613,033	375,744	251,341	167,568	143,711	-137,694	-188,497	270,351	-39,566	180,745	203,819	66,531	517,968
Creditors	234,206	163,253	29,515	-185,851	-39,147	-181,338	-174,157	-84,845	230,278	-254,217	291,908	227,687	47,548	713,373
Accruals and Deferred Income	-360,783	651,419	155,913	50,828	-55,361	93,536	75,420	0	0	0	0	0	0	0
Deferred Taxes & Provisions	13,248	156	-1,016	-222	9,230	-3,088	-6,544	-3,287	9,539	4,375	7,627	-1,498	1,724	2,537
Cash flow from operations	4,411,314	4,368,535	575,444	57,781	-211,373	-7,983	-12,831	257,012	-71,190	90,350	229,513	87,177	-307,762	746,202
Investing Activities
capital expenditure	0	0	-13,991	-19,999	-72,683	-6,814	1,281	-19,998	-87,538	-23,475	-27,315	-8,395	-399,348	-467,956
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	0	0	-13,991	-19,999	-72,683	-6,814	1,281	-19,998	-87,538	-23,475	-27,315	-8,395	-399,348	-467,956
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	-121,331	-221,450	7,660	-113,665	182,548	-42,867	107,080	-39,024	-37,732	-40,422	-4,700	-20,763	344,666	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	-192,463	53,662	8,665	3,880	-20,411	0	81,724	64,943
share issue	0	0	0	0	0	0	0	0	0	0	0	0	-500	1,500
interest	18,745	24,509	-31,647	-39,071	-27,628	-22,108	-18,616	-13,524	-16,104	-18,164	-20,054	-21,366	-10,203	864
cash flow from financing	-102,586	-196,941	-23,987	-152,736	154,920	-64,975	-103,999	1,114	-45,171	-54,706	-45,165	-42,129	415,687	67,307
cash and cash equivalents
cash	-1,279,916	4,130,267	277,773	116,000	-86,671	-146,254	-7,731	238,128	-203,899	12,168	157,032	36,653	-291,422	345,552
overdraft	-376,065	321,003	-259,693	230,954	42,466	-66,483	107,818	0	0	0	0	0	0	0
change in cash	-903,851	3,809,264	537,466	-114,954	-129,137	-79,771	-115,549	238,128	-203,899	12,168	157,032	36,653	-291,422	345,552

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for cambridge bioscience limited. Get real-time insights into cambridge bioscience limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for cambridge bioscience limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

CAMBRIDGE BIOSCIENCE LIMITED group structure

Cambridge Bioscience Limited has no subsidiary companies.

Ultimate parent company

NORDIC BIOSITE HOLDING AB

#0140960

1 parent

CAMBRIDGE BIOSCIENCE LIMITED

04382252

CAMBRIDGE BIOSCIENCE LIMITED Shareholders

europa biosite holding ab

100%

Cambridge Bioscience Limited currently has 1 director, Mr Michael Kerins serving since Nov 2006.

officer	country	age	start	end	role
Mr Michael Kerins		55 years	Nov 2006	-	Director

P&L

September 2022

turnover

16.7m

-28%

operating profit

3.4m

-54%

gross margin

40.2%

-20.74%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

September 2022

net assets

5.2m

-0.31%

total assets

6.9m

-0.3%

cash

3.3m

-0.28%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

fc exports west africa limited

alcan rubber uk limited

beta valve systems ltd

c.w. grain limited

purico (usa) limited

3.5

company number

04382252

Type

Private limited with Share Capital

industry

46180 - Agents specialised in the sale of other particular products

incorporation date

February 2002

age

accounts

Full Accounts

ultimate parent company

NORDIC BIOSITE HOLDING AB

previous names

N/A

incorporated

address

munro house trafalgar way, bar hill, cambridge, CB23 8SQ

last accounts submitted

September 2022

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 8 charges/mortgages relating to cambridge bioscience limited. Currently there are 0 open charges and 8 have been satisfied in the past.

cambridge bioscience limited Company Information

cambridge bioscience limited Estimated Valuation

cambridge bioscience limited Estimated Valuation

cambridge bioscience limited Estimated Valuation

Cambridge Bioscience Limited Overview

Cambridge Bioscience Limited Health Check

CAMBRIDGE BIOSCIENCE LIMITED financials

cambridge bioscience limited Credit Report and Business Information

Cambridge Bioscience Limited Competitor Analysis

cambridge bioscience limited Ownership

cambridge bioscience limited directors

cambridge bioscience limited company details

cambridge bioscience limited Charges & Mortgages

cambridge bioscience limited Companies House Filings - See Documents